Loading... Please wait...

Our Newsletter


MK-0518 (Raltegravir) | HIV-1 integrase inhibitor

  • MK-0518 (Raltegravir).jpg
  • MK-0518 (Raltegravir), 400x400px, png
Price:
$129.00
Catalog #:
C6051-5
Quantity:


Product Description

Raltegravir (Isentress)is an first-in-class, orally-available, oxadiazole-based inhibitor of HIV-1 integrase, inhibiting strand transfer in vitro with an IC50 of 2-7 nM. [1] It is >1000-fold more selective for HIV-1 integrase when compared to other phosphoryltransferases, such as the polymerase and RNase H activities of HIV-1 reverse transcriptase and the human polymerases alpha, beta, and gamma.

Raltegravir has a IC95 in human T lymphoid cell cultures of 31 nM and was also active against HIV-2 when tested in CEMx174 cells, with an IC95 of 6nM. [2]

Raltegravir has been shown to be a potent and selective against Xenotropic murine leukemia-related retrovirus (XMRV) at submicromolar concentrations in MCF-7 breast cancer (EC50 = 5 nM, EC90 = 3.5 uM) and LNCaP prostate cancer (EC50 = 30 nM, EC90 0.46 um) cell lines. [3]


Technical information:

Chemical Formula:   C20H21FN6O5
CAS #:   871038-72-1
Molecular Weight:   444.42
Purity:   >98%
Appearance:   White
Chemical Name:   N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(2-(2-methyl-1,3,4-oxadiazole-5-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide
Solubility:   Up to 100 mM in DMSO
Synonyms:   Raltegravir, MK-0518, MK0518, Isentress

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


Reference:

1. Temesgen et al., Raltegravir: first in class HIV integrase inhibitor. Ther. Clin. Risk Management, 2008, 4(2), 493-500. Pubmed ID: 18728839
2. Hicks et al., Raltegravir: the first HIV type 1 integrase inhibitor. Clin. Infect. Dis. 2009, 48(7), 931-939. Pubmed ID: 19231980
3. Singh et al., Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. PloS ONE 2010, 4(4), e9948. Pubmed ID: 20376347

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the MK-0518 (Raltegravir) | HIV-1 integrase inhibitor to your wish list.

You Recently Viewed...